ePrints

Is HLA type a possible cancer risk modifier in Lynch syndrome?

Lookup NU author(s): Dr Richard Gallon, Dr Mauro Santibanez Koref, Dr Michael Jackson, Dr Gillian Borthwick

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).

Publication metadata

Author(s): Ahadova A, Witt J, Haupt S, Gallon R, Hüneburg R, Nattermann J, Ten Broeke S, Bohaumilitzky L, Hernandez-Sanchez A, Santibanez-Koref M, Jackson MS, Ahtiainen M, Pylvänäinen K, Andini K, Grolmusz VK, Möslein G, Dominguez-Valentin M, Møller P, Fürst D, Sijmons R, Borthwick GM, Burn J, Mecklin JP, Heuveline V, von Knebel Doeberitz M, Seppälä T, Kloor M

Publication type: Review

Publication status: Published

Journal: International Journal of Cancer

Year: 2023

Volume: 152

Issue: 10

Pages: 2024-2031

Print publication date: 15/05/2023

Online publication date: 10/10/2022

Acceptance date: 16/09/2022

ISSN (print): 0020-7136

ISSN (electronic): 1097-0215

URL: https://doi.org/10.1002/ijc.34312

DOI: 10.1002/ijc.34312

Share